Osteoporosis International

Displaying 1 - 6 of 6
Yoel, U., Alkobi Weiss, H., Goldbart, A., Silverman Siris, E., Fisher, D. L., Hassan, L., & Fraenkel, M. (2024). The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates—a single-center retrospective study. Osteoporosis International. https://doi.org/10.1007/s00198-024-07325-9
Publication Date
Kondapalli, A. V., Kamanda-Kosseh, M., Williams, J. M., Shiau, S., Bucovsky, M., Colon, I., Shane, E., & Cohen, A. (2023). Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study. Osteoporosis International, 34(8), 1477–1489. https://doi.org/10.1007/s00198-023-06793-9
Publication Date
Cosman, F., Kendler, D. L., Langdahl, B. L., Leder, B. Z., Lewiecki, E. M., Miyauchi, A., Rojeski, M., McDermott, M., Oates, M. K., Milmont, C. E., Libanati, C., & Ferrari, S. (2022). Romosozumab and antiresorptive treatment: the importance of treatment sequence. Osteoporosis International, 33(6), 1243–1256. https://doi.org/10.1007/s00198-021-06174-0
Publication Date
Cosman, F., Cooper, C., Wang, Y., Mitlak, B., Varughese, S., & Williams, S. A. (2022). Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study. Osteoporosis International, 33(8), 1703–1714. https://doi.org/10.1007/s00198-022-06413-y
Publication Date
Goetz, T. G., Nair, N., Shiau, S., Recker, R. R., Lappe, J. M., Dempster, D. W., Zhou, H., Zhao, B., Guo, X., Shen, W., Nickolas, T. L., Kamanda-Kosseh, M., Bucovsky, M., Stubby, J., Shane, E., & Cohen, A. (2021). In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1. Osteoporosis International, 33(3), 659–672. https://doi.org/10.1007/s00198-021-06196-8
Publication Date